| 2024 | Liu J, Lv X, Ye T, Zhao M, Chen Z, Zhang Y, Yang W, Xie H, Zhan L, Chen L, Liu WC, Su KP, Sun J. Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: A bench-to-bedside translational approach. Brain Behav Immun. 2024 Mar;117:270-282. doi: 10.1016/j.bbi.2024.01.010. Epub 2024 Jan 9. PMID: 38211635. (IF=8.8, Ranking=PSYCHIATRY, 10/276, 3.6%) |
| 2024 | Wang HF, Liu WC, Zailani H, Yang CC, Chen TB, Chang CM, Tsai IJ, Yang CP, Su KP. A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine. Brain Behav Immun. 2024 May;118:459-467. doi: 10.1016/j.bbi.2024.03.019. Epub 2024 Mar 16. PMID: 38499208 (IF=8.8, Ranking=PSYCHIATRY, 10/276, 3.6%) |
| 2024 | Yang CP, Liu WC*, Yang CC, Tsai IJ, Su KP. Refining the understanding of EPA's role in episodic migraine: A response to methodological considerations. Brain Behav Immun. 2024 Jul 16;121:28. doi: 10.1016/j.bbi.2024.07.016. Epub ahead of print. PMID: 39025420. (IF=8.8, Ranking=PSYCHIATRY, 10/276, 3.6%) (Co-first author) |
| 2024 | Zailani H, Wang WL, Satyanarayanan SK, Chiu WC, Liu WC, Sung YS, Chang JP, Su KP. Omega-3 Polyunsaturated Fatty Acids and Blood-Brain Barrier Integrity in Major Depressive Disorder: Restoring Balance for Neuroinflammation and Neuroprotection. Yale J Biol Med. 2024 Sep 30;97(3):349-363. doi: 10.59249/YZLQ4631. PMID: 39351324; PMCID: PMC11426295. (IF=2.5, Ranking=BIOLOGY, 37/109, 33.9%) |
| 2024 | Kuo LF, Liu WC*, Li MF, Huang FH, Chou CK, Chen TH, Tsai YT, Hsu PI, Li CJ, Wu IT, Tsai KF. Prognostic Evaluation of Conversion Therapy Following Hepatic Arterial Infusion Chemotherapy or Immunotherapy in Patients with Advanced or Transarterial Chemoembolization Unsuitable Intermediate-Stage Hepatocellular Carcinoma-A retrospective cohort study. Oncology. 2024 Oct 28:1-30. doi: 10.1159/000542291. Epub ahead of print. PMID: 39467524. (IF=2.5, Ranking=ONCOLOGY, 183/322, 56.8%) (Co-first author) |
| 2024 | Lin YW, Cheng SW, Liu WC, Zailani H, Wu SK, Hung MC, Su KP. Chemogenetic targeting TRPV1 in obesity-induced depression: Unveiling therapeutic potential of eicosapentaenoic acid and acupuncture. Brain Behav Immun. 2024 Oct 23:S0889-1591(24)00669-X. doi: 10.1016/j.bbi.2024.10.028. Epub ahead of print. PMID: 39454693. (IF=8.8, Ranking=PSYCHIATRY, 10/276, 3.6%) |
| 2024 | Wu SK, Yang KJ, Liu WC, Malau IA, Zailani H, Chang CH, Huang SY, Chang JPC, Chiu WC, Su KP.The Efficacy of Omega-3 Fatty Acids as the Monotherapy for Depression: A Randomized, Double-blind, Placebo-controlled Pilot Study. Nutrients 2024, 16(21), 3688; doi:10.3390/nu16213688 (IF=3.2, Ranking=NUTRITION & DIETETICS, 50/114, 43.9%) |
| 2024 | Chang CM, Tsai IJ, Yang CC, Liu WC*, Yang CP. The Impact of Alpha-s1 Casein Hydrolysate On Chronic Insomnia: A Randomized, Double-Blind Controlled Trial. Clinical Nutrition. (IF=6.6, Ranking=NUTRITION & DIETETICS, 10/114, 8.8%) (Corresponding author) |
| 2023 | Wu JS, Hong TC, Wu HT, Lin YJ, Chang TT, Wang CT, Liu WC, Hsieh MT, Wu IC, Chen PJ, Chen CY, Lin SH, Chuang CH, Han MZ, Chen HP, Tsai HM, Kuo HY. Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan. J Gastrointest Oncol. 2023 Apr 29;14(2):849-862. doi: 10.21037/jgo-22-858. Epub 2023 Apr 10. PMID: 37201085; PMCID: PMC10186549. (IF=2.0, Ranking=GASTROENTEROLOGY & HEPATOLOGY, 90/143, 62.9%) |
| 2023 | Chou PH, Liu WC, Lin WH, Hsu CW, Wang SC, Su KP. NIRS-aided differential diagnosis among patients with major depressive disorder, bipolar disorder, and schizophrenia. J Affect Disord. 2023 Nov 15;341:366-373. doi: 10.1016/j.jad.2023.08.101. Epub 2023 Aug 25. PMID: 3763481. (IF=4.9, Ranking=PSYCHIATRY, 38/276, 13.8%) |
| 2023 | Chou PH, Liu WC, Wang SC, Lin WH, Chung YL, Chang CH, Su KP. Associations between frontal lobe activity and depressive symptoms in patients with major depressive disorder receiving rTMS treatment: a near-infrared spectroscopy study. Front Psychiatry. 2023 Aug 16;14:1235713. doi: 10.3389/fpsyt.2023.1235713. PMID: 37654993; PMCID: PMC10466407. (IF=3.2, Ranking=PSYCHIATRY, 88/276, 31.9%) |
| 2023 | Iqbal AZ, Wu SK, Zailani H, Chiu WC, Liu WC, Su KP, Lee SD. Effects of Omega-3 Polyunsaturated Fatty Acids Intake on Vasomotor Symptoms, Sleep Quality and Depression in Postmenopausal Women: A Systematic Review. Nutrients. 2023 Sep 30;15(19):4231. doi: 10.3390/nu15194231. PMID: 37836515; PMCID: PMC10574492. (IF=3.2, Ranking=NUTRITION & DIETETICS, 50/114, 43.9%) |
| 2022 | Tseng CW, Liu WC, Chen CY, Chang TT, Tseng KC. Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV. BMC Infect Dis. 2022 Apr 9;22(1):351. doi: 10.1186/s12879-022-07326-1. PMID: 35397497; PMCID: PMC8994285. (IF=3.4, Ranking=INFECTIOUS DISEASES, 47/132, 35.6%) |
| 2022 | Tseng CW, Liu WC, Ko PH, Chen YC, Tseng KC, Chang TT. The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients. Viruses. 2022 Aug 18;14(8):1812. doi: 10.3390/v14081812. PMID: 36016434; PMCID: PMC9414824. (IF=3.8, Ranking=VIROLOGY, 17/41, 41.5%) |
| 2021 | Wu IC, Liu WC*, Chiu YC, Chiu HC, Cheng PN, Chang TT. Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss. Microorganisms. 2021 May 26;9(6):1146. doi: 10.3390/microorganisms9061146. PMID: 34073483; PMCID: PMC8229518 (IF=4.1, Ranking=MICROBIOLOGY, 49/161, 30.4%) (Co-first author) |
| 2020 | Liu WC, Wu IC, Chiu YC, Tseng KC, Chen CY, Chiu HC, Cheng PN, Chang TT. Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients. Antiviral Res. 2020 Apr;176:104719. doi: 10.1016/j.antiviral.2020.104719. Epub 2020 Jan 28. PMID: 32004619. (IF=4.5, Ranking=PHARMACOLOGY & PHARMACY, 60/354, 16.9%) |
| 2019 | Lin TC, Liu WC, Hsu YH, Lin JJ, Chiu YC, Chiu HC, Cheng PN, Chen CY, Chang TT, Wu IC. Insulin Resistance Associated Disorders Pivoting Long-Term Hepatitis B Surface Antigen Decline During Entecavir Therapy. J Clin Med. 2019 Nov 6;8(11):1892. doi: 10.3390/jcm8111892. PMID: 31698809; PMCID: PMC6912775 |
| 2018 | Lin TC, Chiu YC, Chiu HC, Liu WC, Cheng PN, Chen CY, Chang TT, Wu IC. Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy. World J Gastroenterol. 2018 Feb 14;24(6):725-736. doi: 10.3748/wjg.v24.i6.725. PMID: 29456411; PMCID: PMC5807675. (IF=3.0, Ranking=MEDICINE, GENERAL & INTERNAL, 58/325, 17.8%) |
| 2018 | Wu IC, Liu WC*, Chang TT. Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations. J Biomed Sci. 2018 Jun 2;25(1):51. doi: 10.1186/s12929-018-0442-4. PMID: 29859540; PMCID: PMC5984823. (IF=9.0, Ranking=MEDICINE, RESEARCH & EXPERIMENTAL, 15/189, 7.9%) (Co-first author) |
| 2017 | Ho CH, Tsai HW, Lee CY, Huang LJ, Chien RN, Wu IC, Chiu YC, Liu WC, Cheng PN, Chang TT, Chen SH. Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG. Sci Rep. 2017 May 16;7(1):1957. doi: 10.1038/s41598-017-02158-5. PMID: 28512353;
PMCID: PMC5434008. |
| 2017 | Liu WC, Wu IC, Lee YC, Lin CP, Cheng JH, Lin YJ, Yen CJ, Cheng PN, Li PF, Cheng YT, Cheng PW, Sun KT, Yan SL, Lin JJ, Yang JC, Chang KC, Ho CH, Tseng VS, Chang BC, Wu JC, Chang TT. Hepatocellular carcinoma-associated single-nucleotide
variants and deletions identified by the use of genome-wide high-throughput
analysis of hepatitis B virus. J Pathol. 2017 Oct;243(2):176-192. doi: 10.1002/path.4938. Epub 2017 Aug 17. PMID: 28696069 |
| 2017 | Cheng JH, Liu WC, Chang TT, Hsieh SY, Tseng VS. Detecting exact breakpoints of deletions with diversity in hepatitis B viral genomic DNA from next- generation sequencing data. Methods. 2017 Oct 1;129:24-32. doi: 10.1016/j.ymeth.2017.08.005. Epub 2017 Aug 10. PMID: 28802713 |
| 2016 | Liu WC, Lin CP, Cheng CP, Ho CH, Lan KL, Cheng JH, Yen CJ, Cheng PN, Wu IC,
Li IC, Chang BC, Tseng VS, Chiu YC, Chang TT. Aligning to the sample-specific
reference sequence to optimize the accuracy of next-generation sequencing
analysis for hepatitis B virus. Hepatol Int. 2016 Jan;10(1):147-57. doi:
10.1007/s12072-015-9645-x. Epub 2015 Jul 25. PMID: 26208819; PMCID: PMC4722079 |
| 2016 | Prediction of early hepatocellular carcinoma
recurrence using germinal center kinase-like kinase. |
| 2016 | DeF-GPU: Efficient and effective deletions finding in hepatitis B viral genomic DNA using a GPU architecture. |
| 2015 | Aberrant serum immunoglobulin G glycosylation in
chronic hepatitis B is associated with histological liver damage and reversible
by antiviral therapy |
| 2014 | Efficacy of entecavir in chronic hepatitis B patients with persistently normal
alanine aminotransferase: randomized, double-blind, placebo-controlled study. |
| 2014 | Association of serum IgG N-glycome and transforming growth factor-β1 with
hepatitis B virus e antigen seroconversion during entecavir therapy. |
| 2012 | Analysis of
precore/core covariances associated with viral kinetics and genotypes in
hepatitis B e antigen-positive chronic hepatitis B patients. |
| 2011 | Association of
intrahepatic cccDNA reduction with the improvement of liver histology in chronic
hepatitis B patients receiving oral antiviral agents |
| 2011 | Novel nucleotide and amino acid covariation between the 5'UTR and the
NS2/NS3 proteins of hepatitis C virus: bioinformatic and functional analyses. |
| 2009 | HBV DNA
level as an important determinant of E antigen seroconversion of chronic
hepatitis B during adefovir dipivoxil therapy. |
| 2008 | Genotyping of hepatitis B virus--genotypes a to g by
multiplex polymerase chain reaction. |
| 2007 | Characterization of viral kinetics in patients with hepatitis B e
antigen-positive chronic hepatitis B. |
| 2007 | Five subgenotypes of hepatitis B virus genotype B with distinct
geographic and virological characteristics. |
| 2006 | Simultaneous quantification and genotyping of hepatitis B virus for
genotypes A to G by real-time PCR and two-step melting curve analysis |
| 2003 | Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus
during ribavirin monotherapy |